Navigation Links
Humphrey GPA Glaucoma Progression Analysys Software

ProductsHumphrey GPA Glaucoma Progression Analysys Software
Company Carl Zeiss Meditec, Inc.
Item Humphrey GPA Glaucoma Progression Analysys Software
Features 
  • Plain language explanations simplify interpretation of test results and help quantify likelihood of progression
  • Based on detailed empirical knowledge of glaucoma acquired in extensive multi-center clinical trials worldwide
  • An advanced, proven method to enhance the management of glaucoma
  • Accurately differentiates clinically significant progression of visual field loss from random variability
  • Automatically identifies clinically significant progression
Description Only Humphrey GPA software accurately differentiates clinically significant progression of visual field loss from random variability, providing an advanced, proven method to enhance management of glaucoma for your patients.

The software applies knowledge acquired from a multi-center clinical trial, in which the actual test/retest variability of hundreds of glaucoma patients was measured. By accurately and objectively identifying progressive visual field loss in glaucoma patients, the Humphrey GPA software assists practitioners in making better treatment decisions.

Info Carl Zeiss Meditec, Inc.Call Carl Zeiss Meditec, Inc. to buy products (US and Canada only; other locations use number below) USACanada1-866-407-6044

Customer Service: 877-486-7473
Web site: http://www.meditec.zeiss.com/

Related medicine products :

1. Humphrey Matrix
2. Humphrey Field Analyzer II - i series
3. Humphrey FDT Perimeter
4. Humphrey Atlas Corneal Topography Systems
5. Humphrey Refractor/Keratometer HARK 599
6. Model 350 Humphrey Lens Analyzer
7. Model 360 Humphrey Lens Analyzer
8. Humphrey Field Analyzer II - i series
9. Humphrey FDT Visual Field Instrument
10. Humphrey® Field Analyzer/HFA II-i
11. Humphrey Matrix Perimeter
Full Handle Laseredge Slit Blade Knife, 2.65 mm angled double bevel. Blade tip dimension: N/A x 2.65 mm x N/A....
Full Handle Laseredge Implant Blade Knife, 5.7 mm round tip. Blade dimension: 16.5 mm x 5.7 mm x 4.2 mm x 2.4 mm....
Full Handle Laseredge Implant Blade Knife, 5.2 mm straight. Blade dimension: 16.5 mm x 5.2 mm x 4.2 mm x 1.6 mm....
Full Handle Laseredge Crescent Blade Knife, straight. Blade tip dimension: 12.7 mm x 2.0 mm x 3.8 mm....
Medicine Products:
(Date:12/5/2016)... ... December 05, 2016 , ... As renowned, board-certified dermatologists, Dr. Sabrina G. Fabi ... patients who do not do their research and undergo cosmetic dermatology treatments from unqualified ... midst of a renaissance and every other month a new treatment or device is ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... CardioQuick Patch® significantly improves the reproducibility and accuracy of placing precordial electrodes with ... , Over the last 60 years, studies have shown that single electrode ...
(Date:12/4/2016)... ... ... James Earl Jones is known for myriad roles on stage and screen, he has ... the forthcoming episodes examines mammogram techniques; a very important part of preventative medicine. , ... detection. Like any other disease, treatments have a much higher chance of success if ...
(Date:12/4/2016)... ... December 04, 2016 , ... Patients who wish to gain ... of a cosmetic procedure known as Carbon Dioxide (C02) Fractional Laser Resurfacing ... age spots, fine lines, uneven coloration, wrinkles, scarring, skin laxity or textural ...
(Date:12/2/2016)... ... 02, 2016 , ... Lori G. Cohen and Sara K. ... at the American Conference Institute’s 21st Drug & Medical Device Litigation Conference , ... of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & Health ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... , December 5, 2016 PharmaBoardroom today releases ... . ... This report offers companies, investors, policymakers, and stakeholders crucial insight ... of Europe , home to some of the world,s ... pharmaceutical companies in Novartis and Roche, and with a number one ranking ...
(Date:12/5/2016)... and TAIPEI, Taiwan , Dec. 5, 2016 ... treatment ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) in Complete ... better safety and tolerability profile of ropeginterferon alfa-2b versus HU ... and the ongoing long-term follow-up trial CONTINUATION-PV to obtain European ... intends to present this data to the FDA as it ...
(Date:12/4/2016)... Attorney General of Louisiana , Charles ... firm of Kahn Swick & Foti, LLC ("KSF"), announces that ... LCI ). On November 3, ... in Generic-Drug Probe to Be Filed by Year-End," which reported ... two years ago, now spans more than a dozen companies," ...
Breaking Medicine Technology: